| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
GPCR GPR87 Blocking Peptide is synthetically produced from the 1-60 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Dilution Range: |
WB: IHC: 1:100 |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
GPR87 |
| Gene ID: |
53836 |
| Uniprot ID: |
GPR87_HUMAN |
| Immunogen Region: |
1-60 |
| Immunogen: |
Synthetic peptide taken within amino acid region 1-60 on human GPCR87 protein. |
| Tissue Specificity | Expressed in placenta and prostate. Weaker expression in thymus. Not expressed in thalamus, hippocampus, pons or cerebellum. Overexpressed in squamous cell carcinoma of the lung. |
| Function | Receptor for lysophosphatidic acid (LPA). Necessary for p53/TP53-dependent survival in response to DNA damage. |
| Peptide Name | G-Protein Coupled Receptor 87G-Protein Coupled Receptor 95 |
| Cellular Localisation | Cell MembraneMulti-Pass Membrane Protein |
| Alternative Peptide Names | G-Protein Coupled Receptor 87 proteinG-Protein Coupled Receptor 95 proteinGPR87 proteinGPR95 proteinFKSG78 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
